Treating or preventing restless legs syndrome using prodrugs of GABA analogs

Details for Australian Patent Application No. 2004274002 (hide)

Owner Xenoport, Inc.

Inventors Canafax, Daniel M.; Barrett, Ronald W.

Agent Davies Collison Cave

Pub. Number AU-B-2004274002

PCT Pub. Number WO2005/027850

Priority 60/504,726 18.09.03 US; 60/512,279 17.10.03 US; 60/504,172 17.09.03 US; 60/538,495 22.01.04 US

Filing date 17 September 2004

Wipo publication date 31 March 2005

Acceptance publication date 28 April 2011

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

6 April 2006 PCT application entered the National Phase

  PCT publication WO2005/027850 Priority application(s): WO2005/027850

28 April 2011 Application Accepted

  Published as AU-B-2004274002

25 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004274003-Method for bone structure prognosis and simulated bone remodeling

2004274000-Pharmaceutical delivery system